Polycythemia is a blood disorder where the body produces too many red blood cells. It can be primary, caused by problems in bone marrow production of red blood cells, or secondary, caused by factors like lung or heart diseases that result in low oxygen levels triggering high red blood cell production. Symptoms include feeling tired, shortness of breath, headaches, and itchy skin. Diagnosis involves blood tests showing high red blood cell counts and hematocrit levels. Treatment focuses on phlebotomy to reduce red blood cell counts through blood removal, along with medications in some cases to suppress bone marrow production of red blood cells.
Polycythemia is a rare bone marrow disorder, which causes the increase in the production of cells in the blood, mainly red blood cells. The primary function of the red blood cells is to carry oxygen to the different parts of the body.
Polycythemia is a rare bone marrow disorder, which causes the increase in the production of cells in the blood, mainly red blood cells. The primary function of the red blood cells is to carry oxygen to the different parts of the body.
This PPT covers pathophysiology of thrombocytopenia which includes causes of thrombocytopenia, symptoms of thrombocytopenia and diagnosis of thrombocytopenia
The terms leukopenia and neutropenia are often used interchangeably. However, they refer to slightly different conditions. Leukopenia is an umbrella term that refers to a reducation in any of the white blood cell types.
Neutropenia is a type of leukopenia but refers specifically to a decrease in neutrophils, the most common type of white blood cell. A person’s neutrophil count is an important indicator of their infection risk.
an abnormally increased concentration of haemoglobin in the blood, either through reduction of plasma volume or increase in red cell numbers. It may be a primary disease of unknown cause, or a secondary condition linked to respiratory or circulatory disorder or cancer.
This PPT covers pathophysiology of thrombocytopenia which includes causes of thrombocytopenia, symptoms of thrombocytopenia and diagnosis of thrombocytopenia
The terms leukopenia and neutropenia are often used interchangeably. However, they refer to slightly different conditions. Leukopenia is an umbrella term that refers to a reducation in any of the white blood cell types.
Neutropenia is a type of leukopenia but refers specifically to a decrease in neutrophils, the most common type of white blood cell. A person’s neutrophil count is an important indicator of their infection risk.
an abnormally increased concentration of haemoglobin in the blood, either through reduction of plasma volume or increase in red cell numbers. It may be a primary disease of unknown cause, or a secondary condition linked to respiratory or circulatory disorder or cancer.
THROMBOCYTOPENIA is decreased platelet count we call it thrombocytopenias. causes of this are called an infection, cancer condition, some type of the drugs like heparin, etc. signs and symptoms of the is bleeding tendency patiche, purpuraetc/ the management of this is plasma transfusion admin situation of some of the drug immunotherapy is helpful for this condition. surgery splenectomy.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. POLYCYTHEMIA
• Polycythemia is a blood disorder in which the
body produces too many red blood cells as a
result of a problem with the bone marrow or an
increased production of the hormone
erythropoietin (EPO).
• Polycythemia is normally reported in terms of
Increased hematocrit
Hemoglobin concentration.
3. • The normal range for hematocrit varies between sexes and is
approximately 45% to 52% for men and 37% to 48% for women.
• Polycythemia is considered when the hematocrit is greater than 48% in
women and 52% in men.
• The normal range for hemoglobin is: For men, 13.5 to 17.5 grams per
deciliter. For women, 12.0 to 15.5 grams per deciliter.
• Hemoglobin (HGB): Polycythemia is considered when there is a
hemoglobin level of greater than 16.5g/dL in women or hemoglobin level
greater than18.5 g/dL in men.
4. CLASIFICATION
• Polycythemia can be divided into two categories:
• Relative polycythemia
• Absolute polycythemia
primary polycythemia
secondary polycythemia
6. PRIMARY POLYCYTHEMIA OR
POLYCYTHEMIA VERA
• In primary polycythemia the increase in red blood cells
is caused by inherent problems in the process of red
blood cell production.
• Red cell production (erythropoiesis) takes place in the
bone marrow .
• Polycythemia vera is rare.
• It usually develops slowly, and you might have it for
years without knowing.
• Often the condition is found during a blood test done for
another reason.
7. NEONATAL (NEWBORN) POLYCYTHEMIA
• Neonatal polycythemia can be seen in 1% to 5% of newborns.
• The most common causes may be related to
Transfusion of blood
Transfer of placental blood to the infant after delivery
Chronic inadequate oxygenation of the fetus (intrauterine
hypoxia) due to placental insufficiency.
9. CAUSES OF POLYCYTHEMIA VERA
• Polycythemia vera occurs when a mutation in a gene causes a problem
with blood cell production.
• Genetic mutations of the JAK2 gene were found to be responsible for
most cases of polycythemia vera.
• These mutations are thought to possibly increase the sensitivity of the
red blood cell precursors to erythropoietin, thereby, increasing red blood
cell production.
• The cause of the gene mutation in polycythemia vera is unknown, but it's
generally not inherited from your parents.
10. CAUSES OF SECONDARY POLYCYTHEMIA
• In secondary polycythemia, factors external to red blood cell production
result in polycythemia.
• Secondary polycythemia most often develops as a response to chronic
hypoxemia, which triggers increased production of erythropoietin by the
kidneys.
• The most common causes of secondary polycythemia include
obstructive sleep apnea, obesity hypoventilation syndrome, and chronic
obstructive pulmonary disease (COPD)
• Other causes include testosterone replacement therapy and heavy
cigarette smoking.
11. COMPLICATIONS OF POLYCYTHEMIA VERA
• Blood clots: Increased blood thickness and decreased blood flow, as
well as abnormalities in your platelets, raise your risk of blood clots.
• Enlarged spleen: The increased number of blood cells caused by
polycythemia vera makes your spleen work harder than normal, which
causes it to enlarge.
• Other complications, including open sores on the inside lining of your
stomach, upper small intestine or esophagus (peptic ulcers) and
inflammation in your joints (gout).
• Other blood disorders
12. COMPLICATIONS OF SECONDARY
POLYCYTHEMIA
• Excessive polycythemia occur when hematocrit levels higher than 65-
70%, may result in increased whole blood viscosity.
• This, in turn, may lead to impaired blood flow locally, resulting in
thrombosis.
• Hyperviscosity may also lead to generalized sluggish blood flow,
resulting in impaired tissue oxygenation in multiple organs, which may
lead to decreased mentation, fatigue, generalized weakness, and poor
exercise tolerance.
13. DIAGNOSIS
HISTORY COLLECTION AND PHYSICAL EXAMINATION
History usually includes questions about smoking, living at high altitudes,
breathing difficulty, sleep disturbances and chronic cough.
Blood tests
The blood studies will show
An increase in the
number of red blood cells
Elevated levels of
hemoglobin
Elevated hematocrit
measurement
Very low levels of
erythropoietin
14. BONE MARROW ASPIRATION OR BIOPSY
• A bone marrow biopsy involves taking a
sample of solid bone marrow material.
• If an examination of the bone marrow
shows that it's producing higher than
normal numbers of blood cells, it may be a
sign of polycythemia.
Bone marrow biopsy
16. TREATMENT
Phlebotomy or Blood withdrawals:
• The most common treatment for polycythemia vera is having
frequent blood withdrawals, using a needle in a vein
(phlebotomy). It's the same procedure used for donating blood.
• This reduces the number of blood cells and decreases your
blood volume, making it easier for your blood to function
properly.
17. LOW-DOSE ASPIRIN
The doctor may recommend that to take a low dose of aspirin to reduce
your risk of blood clots. Low-dose aspirin may also help reduce burning
pain in your feet or hands
Therapy to reduce itching
If you have bother some itching, the doctor may prescribe medication, such
as antihistamines, or recommend ultraviolet light treatment to relieve your
discomfort
18. MEDICATION TO DECREASE BLOOD
CELLS
• For people with polycythemia, who aren't helped by phlebotomy alone,
medications, such as hydroxyurea (Droxia, Hydrea), to suppress the
bone marrow's ability to produce blood cells may be used.
• Interferon alpha may be used to stimulate the immune system to fight
the overproduction of red blood cells
19. LIFESTYLE AND HOME REMEDIES
• Exercise
• Avoid tobacco
• Watch for sores
• Be good to your skin
• Avoid extreme temperature